Marie O'brien, DO | |
3080 Hamilton Blvd, Suite 300, Allentown, PA 18103-3694 | |
(610) 776-5038 | |
Not Available |
Full Name | Marie O'brien |
---|---|
Gender | Female |
Speciality | Rheumatology |
Experience | 22 Years |
Location | 3080 Hamilton Blvd, Allentown, Pennsylvania |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1083836464 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RR0500X | Internal Medicine - Rheumatology | OS012497 (Pennsylvania) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Lehigh Valley Hospital | Allentown, PA | Hospital |
Schuylkill Medical Center - South Jackson Street | Pottsville, PA | Hospital |
St Luke's Hospital Bethlehem | Bethlehem, PA | Hospital |
Lehigh Valley Hospital - Pocono | East stroudsburg, PA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Lehigh Valley Physician Group | 3072425123 | 1763 |
News Archive
GenomeDx Biosciences today announced that a draft local coverage determination (LCD) for its Decipher® Prostate Cancer Classifier has been published by the Centers for Medicare and Medicaid Services (CMS) describing a coverage and payment policy for use of the Decipher test in men who have undergone radical prostatectomy.
Use of torture around the world has not diminished but the techniques used have grown more complex and sophisticated, according to new research from Queen Mary, University of London.
Neiker-Tecnalia, the Basque Institute for Agricultural Research and Development, and the company FARMARABA S.L. are working together on a Project designed to produce Omega 3 using marine plant micro-organisms. The ultimate aim is to develop in-house technologies to obtain this highly valued fatty acid, and then apply them at a FARMARABA production plant.
The division of rheumatic diseases in the Department of Internal Medicine at UT Southwestern Medical Center has been awarded a five-year, $5 million grant from the National Institutes of Health to fund the Center of Research Translation, which will investigate the autoimmune disease systemic lupus erythematosus (SLE).
Tufts Medical Center researchers are developing a first-of-its-kind drug to prevent deadly blood clots in heart disease patients, without the risk of serious bleeding associated with current medications. The National Heart, Lung, and Blood Institute of the National Institutes of Health has just awarded the team led by Athan Kuliopulos, MD, PhD, a $10 million grant to start testing a drug based on this novel technology.
› Verified 1 days ago
Entity Name | Lehigh Valley Physician Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1457309650 PECOS PAC ID: 3072425123 Enrollment ID: O20040227000335 |
News Archive
GenomeDx Biosciences today announced that a draft local coverage determination (LCD) for its Decipher® Prostate Cancer Classifier has been published by the Centers for Medicare and Medicaid Services (CMS) describing a coverage and payment policy for use of the Decipher test in men who have undergone radical prostatectomy.
Use of torture around the world has not diminished but the techniques used have grown more complex and sophisticated, according to new research from Queen Mary, University of London.
Neiker-Tecnalia, the Basque Institute for Agricultural Research and Development, and the company FARMARABA S.L. are working together on a Project designed to produce Omega 3 using marine plant micro-organisms. The ultimate aim is to develop in-house technologies to obtain this highly valued fatty acid, and then apply them at a FARMARABA production plant.
The division of rheumatic diseases in the Department of Internal Medicine at UT Southwestern Medical Center has been awarded a five-year, $5 million grant from the National Institutes of Health to fund the Center of Research Translation, which will investigate the autoimmune disease systemic lupus erythematosus (SLE).
Tufts Medical Center researchers are developing a first-of-its-kind drug to prevent deadly blood clots in heart disease patients, without the risk of serious bleeding associated with current medications. The National Heart, Lung, and Blood Institute of the National Institutes of Health has just awarded the team led by Athan Kuliopulos, MD, PhD, a $10 million grant to start testing a drug based on this novel technology.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Marie O'brien, DO Po Box 783311, Philadelphia, PA 19178-3311 Ph: () - | Marie O'brien, DO 3080 Hamilton Blvd, Suite 300, Allentown, PA 18103-3694 Ph: (610) 776-5038 |
News Archive
GenomeDx Biosciences today announced that a draft local coverage determination (LCD) for its Decipher® Prostate Cancer Classifier has been published by the Centers for Medicare and Medicaid Services (CMS) describing a coverage and payment policy for use of the Decipher test in men who have undergone radical prostatectomy.
Use of torture around the world has not diminished but the techniques used have grown more complex and sophisticated, according to new research from Queen Mary, University of London.
Neiker-Tecnalia, the Basque Institute for Agricultural Research and Development, and the company FARMARABA S.L. are working together on a Project designed to produce Omega 3 using marine plant micro-organisms. The ultimate aim is to develop in-house technologies to obtain this highly valued fatty acid, and then apply them at a FARMARABA production plant.
The division of rheumatic diseases in the Department of Internal Medicine at UT Southwestern Medical Center has been awarded a five-year, $5 million grant from the National Institutes of Health to fund the Center of Research Translation, which will investigate the autoimmune disease systemic lupus erythematosus (SLE).
Tufts Medical Center researchers are developing a first-of-its-kind drug to prevent deadly blood clots in heart disease patients, without the risk of serious bleeding associated with current medications. The National Heart, Lung, and Blood Institute of the National Institutes of Health has just awarded the team led by Athan Kuliopulos, MD, PhD, a $10 million grant to start testing a drug based on this novel technology.
› Verified 1 days ago
Jessica Mary Boehmler, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1250 S Cedar Crest Blvd, Suite 205, Allentown, PA 18103 Phone: 610-439-8856 Fax: 610-439-8856 | |
Allison Jane Baragona, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1501 N Cedar Crest Blvd Ste 110, Allentown, PA 18104 Phone: 610-821-2828 Fax: 610-821-7915 | |
James A Burke, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1250 S Cedar Crest Blvd, Suite 300, Allentown, PA 18103 Phone: 610-402-3110 Fax: 610-402-3112 | |
Stephen R Shore, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1901 Hamilton St Ste 300, Allentown, PA 18104 Phone: 610-628-7900 Fax: 833-816-7513 | |
Tarika Sejal Chowdhary, MD Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 17th & Chew, Suite 101, Allentown, PA 18105 Phone: 610-969-4370 | |
Ashley Vojtek, DO Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 1200 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 484-862-3200 | |
Dr. Ian William Klansek, MD Rheumatology Medicare: Medicare Enrolled Practice Location: 2490 Schoenersville Rd, Allentown, PA 18109 Phone: 484-526-7262 |